(EPC) Edgewell Personal Care - Overview
Stock: Razors, Sunscreen, Wipes, Tampons
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.56% |
| Yield on Cost 5y | 1.91% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 62.5% |
| Payout Ratio | 27.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.3% |
| Relative Tail Risk | -2.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.90 |
| Alpha | -44.35 |
| Character TTM | |
|---|---|
| Beta | 0.615 |
| Beta Downside | 0.413 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.11% |
| CAGR/Max DD | -0.33 |
Description: EPC Edgewell Personal Care January 18, 2026
Edgewell Personal Care Co. (NYSE:EPC) manufactures and markets a broad portfolio of personal-care products worldwide through three operating segments: Wet Shave (Schick, Wilkinson Sword, Billie, etc.), Sun & Skin Care (Banana Boat, Hawaiian Tropic, Wet Ones, Cremo), and Feminine Care (Playtex, o.b., Stayfree, Carefree). The company sells both under its own brands and via private-label agreements, using a mix of direct sales forces and third-party distributors.
In FY 2023 the firm generated roughly **$3.9 billion** in revenue, with the Wet Shave segment contributing about 55 % of total sales and delivering an adjusted EBITDA margin near **12 %**, while Sun & Skin Care and Feminine Care posted margins of 9 % and 7 % respectively. Recent quarterly reports show a **4-5 %** year-over-year increase in net sales, driven by higher pricing power and a modest rebound in discretionary consumer spending.
Key macro drivers for EPC include ongoing **inflationary pressure on raw material costs** (e.g., aluminum for razor handles, petro-based plastics for packaging), which compresses margins unless offset by price hikes or product mix shifts. Additionally, the **trend toward premium, sustainable personal-care products** is reshaping the competitive landscape, prompting Edgewell to invest in eco-friendly formulations and refillable razor systems to capture higher-margin segments.
For a deeper dive into EPC’s valuation metrics and scenario analysis, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 25.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -3.58 > 1.0 |
| NWC/Revenue: 19.34% < 20% (prev 16.52%; Δ 2.81% < -1%) |
| CFO/TA 0.03 > 3% & CFO 118.4m > Net Income 25.4m |
| Net Debt (1.19b) to EBITDA (185.6m): 6.40 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago -7.19% < -2% |
| Gross Margin: 41.60% > 18% (prev 0.42%; Δ 4117 % > 0.5%) |
| Asset Turnover: 59.39% > 50% (prev 60.41%; Δ -1.01% > 0%) |
| Interest Coverage Ratio: 1.32 > 6 (EBITDA TTM 185.6m / Interest Expense TTM 73.2m) |
Altman Z'' 2.33
| A: 0.11 (Total Current Assets 995.5m - Total Current Liabilities 565.5m) / Total Assets 3.76b |
| B: 0.29 (Retained Earnings 1.09b / Total Assets 3.76b) |
| C: 0.03 (EBIT TTM 96.8m / Avg Total Assets 3.74b) |
| D: 0.44 (Book Value of Equity 977.6m / Total Liabilities 2.20b) |
| Altman-Z'' Score: 2.33 = BBB |
Beneish M -3.16
| DSRI: 0.85 (Receivables 137.8m/164.1m, Revenue 2.22b/2.25b) |
| GMI: 1.02 (GM 41.60% / 42.41%) |
| AQI: 1.01 (AQ_t 0.64 / AQ_t-1 0.63) |
| SGI: 0.99 (Revenue 2.22b / 2.25b) |
| TATA: -0.02 (NI 25.4m - CFO 118.4m) / TA 3.76b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of EPC shares?
Over the past week, the price has changed by +6.63%, over one month by +20.92%, over three months by +11.92% and over the past year by -33.51%.
Is EPC a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EPC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.3 | 7.6% |
| Analysts Target Price | 22.3 | 7.6% |
| ValueRay Target Price | 19.6 | -5.4% |
EPC Fundamental Data Overview February 03, 2026
P/E Forward = 8.0192
P/S = 0.4088
P/B = 0.5682
P/EG = 2.39
Revenue TTM = 2.22b USD
EBIT TTM = 96.8m USD
EBITDA TTM = 185.6m USD
Long Term Debt = 1.38b USD (from longTermDebt, last quarter)
Short Term Debt = 29.5m USD (from shortTermDebt, last quarter)
Debt = 1.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19b USD (from netDebt column, last quarter)
Enterprise Value = 2.10b USD (909.1m + Debt 1.41b - CCE 225.7m)
Interest Coverage Ratio = 1.32 (Ebit TTM 96.8m / Interest Expense TTM 73.2m)
EV/FCF = 50.63x (Enterprise Value 2.10b / FCF TTM 41.4m)
FCF Yield = 1.98% (FCF TTM 41.4m / Enterprise Value 2.10b)
FCF Margin = 1.86% (FCF TTM 41.4m / Revenue TTM 2.22b)
Net Margin = 1.14% (Net Income TTM 25.4m / Revenue TTM 2.22b)
Gross Margin = 41.60% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 38.83% (prev 42.81%)
Tobins Q-Ratio = 0.56 (Enterprise Value 2.10b / Total Assets 3.76b)
Interest Expense / Debt = 1.05% (Interest Expense 14.8m / Debt 1.41b)
Taxrate = 21.0% (US default 21%)
NOPAT = 76.5m (EBIT 96.8m * (1 - 21.00%))
Current Ratio = 1.76 (Total Current Assets 995.5m / Total Current Liabilities 565.5m)
Debt / Equity = 0.91 (Debt 1.41b / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = 6.40 (Net Debt 1.19b / EBITDA 185.6m)
Debt / FCF = 28.67 (Net Debt 1.19b / FCF TTM 41.4m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.68% (Net Income 25.4m / Total Assets 3.76b)
RoE = 1.66% (Net Income TTM 25.4m / Total Stockholder Equity 1.53b)
RoCE = 3.32% (EBIT 96.8m / Capital Employed (Equity 1.53b + L.T.Debt 1.38b))
RoIC = 2.58% (NOPAT 76.5m / Invested Capital 2.97b)
WACC = 3.71% (E(909.1m)/V(2.32b) * Re(8.18%) + D(1.41b)/V(2.32b) * Rd(1.05%) * (1-Tc(0.21)))
Discount Rate = 8.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.04%
[DCF Debug] Terminal Value 84.95% ; FCFF base≈94.6m ; Y1≈83.2m ; Y5≈68.2m
Fair Price DCF = 18.84 (EV 2.07b - Net Debt 1.19b = Equity 880.3m / Shares 46.7m; r=5.90% [WACC]; 5y FCF grow -14.76% → 2.90% )
EPS Correlation: -20.66 | EPS CAGR: -36.67% | SUE: 1.09 | # QB: 1
Revenue Correlation: 17.84 | Revenue CAGR: 4.03% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.73 | Chg30d=+0.017 | Revisions Net=-3 | Analysts=7
EPS current Year (2026-09-30): EPS=2.34 | Chg30d=-0.018 | Revisions Net=-3 | Growth EPS=-7.3% | Growth Revenue=+1.6%
EPS next Year (2027-09-30): EPS=2.50 | Chg30d=-0.037 | Revisions Net=-4 | Growth EPS=+7.1% | Growth Revenue=+1.3%